RELFYDESS sol inj 150 U/1.5 ml 10 flac 1.5 ml
7680696200026
CH-69620
M03AX01
01.13.0.
1 / 3
google
Details
- Product number
- 6962001
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- toxinum botulinicum A (stirpis I01) 150 U., dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, kalii chloridum, natrii chloridum, polysorbatum 80, tryptophanum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 5.4 mg et kalium 0.18 mg.
Articles (1)
Relfydess 150 units/ 1,5 ml, Injektionslösung
Injektionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.4 MG | Substance | HBESI |
|
(N/A)
|
0.18 MG | Substance | HBESI |
Authorization holder
IPSEN Pharma Schweiz GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 69620
- Drug name
- Relfydess, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- M03AX01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/03/2025
- Authorization expiration date
- 09/03/2030
- IT number
- 01.13.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RELFYDESS sol inj 150 U/1.5 ml 10 flac 1.5 ml
- Description (DE)
- RELFYDESS Inj Lös 150 E/1.5 ml 10 Durchstf 1.5 ml
- Market launch
- 10/03/2025
- Narcotic (BTM)
- No